Sign up today to learn more about Emulate stock
EquityZen is a marketplace for shares of proven pre IPO tech companies
Emulate Stock
Organs-on-Chips Company
About Emulate Stock
Emulate develops Organs-on-Chips technologies through an automated human bioemulation platform that aims to mimic true human physiology so that responses to medicines, chemicals, and diseases can be accurately predicted. Through co-innovation with collaborators and internal programs, Emulate aims to advance product innovation, design, and safety across a range of applications in drug development, personalized medicine, agriculture, and chemical-based consumer products.
Emulate was founded in 2013 and is based in Bostom, MA. Notable investors in Emulate include Founders Fund, Glass Wall Syndicate, and Starlight Ventures.
Investors
ALS Finding a Cure
ALS Investment Fund
Alumni Ventures Group
Lacework, Getaround, GrubMarket, Better.com, Groq, Divergent 3D, SonderMind, Plastiq, Accolade, Madison Reed
ATEL Ventures
Blue Ivy Ventures
Wheels Up, Divergent 3D, Plastiq, Upstart, Emulate, Shift, OpenGov, Tamr, Freshly, Humatics
Cedars Sinai Medical Center
Founders Fund
Lyft, SpaceX, Spotify, Airbnb, Stripe, Anduril Industries, Flexport, Palantir Technologies, Wish, Compass
Glass Wall Syndicate
LabCorp
NanoDimension
National Institutes of Health
Northpond Ventures
OS Fund
Pivot Bio, Emulate, Tempo Automation, Human Longevity, Verge Genomics, Elysium Health, uBiome, 3T Biosciences
Perceptive Advisors
Zymergen, Freenome, Omada Health, Crossover Health, Twin Health, Emulate, PROCEPT BioRobotics, AEGEA Medical, Saama
SciFi VC
Zymergen, PsiQuantum, Anchorage Digital, Synthego, Virta Health, Emulate
Starlight Ventures
Techammer
Cityblock Health, EverlyWell, Imperfect Foods, Emulate, Pymetrics
Funding History
| July 2014 | $12.0M |
|---|---|
| March 2016 | $45.0M |
| June 2018 | $36.0M |
| August 2019 | $28.2M |
| August 2021 | $20.7M |
| August 2021 | $60.4M |
Management
Chief Executive Officer
Jim Corbett
Chief Financial Officer
Scott Kantor
Press
biospace - Nov, 17 2021
TechCrunch - Sep, 8 2021
medcitynews - Aug, 25 2021
drugdiscoverytrends - Mar, 18 2021
PR Newswire - Jan, 11 2021
PR Newswire - Jan, 8 2021
Bio Space - Dec, 21 2020
PR Newswire - Dec, 8 2020
Technology Networks - Nov, 24 2020
xconomy - Mar, 23 2020
eurekalert - Mar, 19 2020
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
